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ABSTRACT 18 
Background 19 
Rheumatoid arthritis (RA) has articular and non-articular manifestations. Early, intensive treatment 20 
has substantial benefit for both. This requires patients be identified as soon as symptoms develop.  21 
Objectives 22 
To determine whether selected signs and symptoms can be identified in the primary care records of 23 
patients prior to a formal diagnosis of RA being made and, if so, how early they can be identified. 24 
Methods 25 
A case-control study was constructed within the UK Clinical Practice Research Datalink (CPRD). 3577 26 
individuals with ‘definite’ RA, were matched to 14287 individuals without inflammatory arthritis. An 27 
index date was established (i.e. date general practitioner (GP) first appeared to suspect RA). Rates of 28 
consultation and consultations for suspected early RA symptoms were compared in cases and 29 
controls in the two years prior to the index date using conditional logistic regression, adjusted for 30 
number of consultations. 31 
Results 32 
The mean (standard deviation) age of participants was 58.8 (14.5) years and 66.8% were female. 33 
Rates of any consultation were significantly higher in RA cases than in controls for at least two years 34 
prior to the index date. Cases were more likely to have a pre-diagnosis coded consultation for joint, 35 
and particularly hand symptoms (aOR 11.44 (9.60, 13.63)), morning stiffness (8.10 (3.54, 18.5)), 36 
carpal tunnel syndrome (4.57 (3.54, 5.88)) and other non-articular features.  37 
Conclusions 38 
In patients who develop RA, GP consultation rates are higher for at least two years prior to the first 39 
recorded suspicion of RA. This study highlights symptoms that should raise a GP’s index of suspicion 40 
for RA.  41 
 42 
KEY WORDS: Rheumatoid arthritis; Diagnosis;  Primary care43 
  
3 
 
INTRODUCTION 44 
Rheumatoid arthritis (RA) causes joint pain, stiffness and damage and can lead to excess morbidity 45 
and mortality. It has a prevalence in the UK of around 0.67% [1]. It is known that early, intensive 46 
treatment can increase the likelihood of remission and reduce long term joint damage and 47 
comorbidities [2,3].  48 
Delay in making a diagnosis of RA, and therefore in treating it, can occur at a number of points in the 49 
patient journey [3-6]; first in the patient recognising their symptoms and seeking help from primary 50 
care, second in the primary care physician recognising the potential for a diagnosis of RA and making 51 
a referral to a rheumatology specialist, and third in seeing a rheumatologist and starting appropriate 52 
treatment. Work has been ongoing to understand the causes of patient delay [7-12], which has 53 
comprised in-depth studies of the symptoms reported by patients prior to their diagnosis of RA [13-54 
16]. These symptoms have included problems with joints, fatigue, weakness [13], muscle cramps, 55 
psychological distress, and loss of motor control [14]. 56 
Primary care delay continues to be a significant contributor to overall diagnostic delay for people 57 
with RA [17]. This could be because GPs are not aware of the need to refer quickly [18], or because 58 
they find it difficult to identify ‘red flag’ symptoms, for example because of co-existing 59 
musculoskeletal conditions [19,20]. We hypothesised that we would be able to identify signs and 60 
symptoms in the coded part of the medical record that increase the likelihood of a future RA 61 
diagnosis, increasing GPs awareness and facilitating a more rapid referral.  62 
We present a case-control study to assess the association of clinical features reported by patients in 63 
the earliest phases of RA with future diagnosis of the condition using the UK Clinical Practice 64 
Research Datalink (CPRD).  65 
 66 
MATERIALS AND METHODS 67 
Data source: the Clinical Practice Research Datalink 68 
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The CPRD is an anonymised source of routinely collected primary care health records covering 69 
approximately 6.9% of the UK’s population. It is broadly representative of this population in terms of 70 
age, sex and ethnicity [21]. The data exist in coded form and include details of symptoms, diagnoses 71 
and prescriptions. Clinical data are assigned Read codes (the hierarchical clinical coding system 72 
currently used in UK primary care) by the GP. Data are collected for clinical purposes and so it can be 73 
assumed that anything the GP considers relevant might be coded, regardless of whether any clinical 74 
action was required as a result. The coding of data has been shown to be accurate for a range of 75 
conditions [22]. The CPRD assigns an ‘up-to-standard’ date for when a practice has a high enough 76 
quality of coding to be used for research. We use only up-to-standard data in this study.  77 
 78 
Definition of rheumatoid arthritis  79 
Previous work in the General Practice Research Database (predecessor to CPRD) developed an 80 
algorithm to identify individuals with RA [23]. The algorithm combines Read codes for RA with 81 
prescription information and potential alternative diagnoses to create a case definition that is 82 
specific, but not overly sensitive. It has been updated to allow for the inclusion of new Read codes 83 
and the use of biological disease modifying anti-rheumatic drugs (DMARD) [24].  84 
 85 
Analysis sample 86 
All individuals with a first Read code for RA in the CPRD between 2007 and 2012 were identified and 87 
the algorithm to define RA was applied [24]. Those who met this specific definition of RA were then 88 
matched to four individuals of the same sex and from the same practice who were born in the same 89 
3-year time interval who did not have a Read code for any inflammatory arthropathy up until the 90 
time of the case’s first RA code, in order to form a case-control study. 91 
 92 
The index date: first indication of RA in the records 93 
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The date at which the first RA Read code was recorded may not accurately reflect the date at which 94 
the GP first suspected RA in the patient [25,26], as he/she may wait until diagnosis is confirmed by a 95 
specialist before entering this diagnostic code. As a proxy for the date of first clinical suspicion of RA, 96 
an index date was defined. Based on previous work in the CPRD [27,28], this index date was taken to 97 
be the earliest of the first RA code, or other code from the Read code subchapter N04 (rheumatoid 98 
arthritis and other inflammatory arthropathy), the date of the first prescription of a DMARD or first 99 
referral to rheumatology in the three years preceding the first RA Read code (Figure 1). 100 
 101 
Early signs and symptoms  102 
Signs and symptoms that may precede a diagnosis of RA were identified from the literature [13-16] 103 
and consultation with experts. Whilst some of the signs/symptoms described in the literature were 104 
not possible to define within the medical record (e.g. muscle burning as one would feel after 105 
exercise), other signs/symptoms were clearly defined syndromes and conditions that could be 106 
specified and studied in more detail (e.g. carpal tunnel syndrome, shoulder pain).  107 
The final set of the signs/symptoms included is given in Tables 2 (articular) and 3 (non-articular). Lists 108 
of Read codes to define each sign/symptom, the concepts they represent and the process to achieve 109 
the lists are available at [29]. 110 
Where a sign/symptom was not recorded, it was assumed that the individual did not experience it, 111 
rather than data being missing.  112 
 113 
Statistical analyses 114 
Rates of consultation 115 
A consultation was defined as a day on which a Read coded contact with the practice was made. 116 
Where there were multiple contacts/Read codes on the same day, only one was included in the 117 
consultation rate analysis. Monthly rates of consultations in the 2-year period before the index date 118 
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were estimated and compared in cases and controls using incidence rate ratios with 95% confidence 119 
intervals (CI). 120 
 121 
Signs and symptoms associated with RA 122 
We investigated signs/symptoms in the 2-year period prior to the index date. Cumulative time 123 
periods were defined at 1, 6, 12 and 24 months prior to the index date. Each period included 124 
previous periods (Figure 1). Additionally, we considered the period 12 to 24 months before the index 125 
date to allow comparison with the period 0 to 12 months before the index date. In these analyses all 126 
Read coded contacts were considered, even when multiple codes were entered on the same date.  127 
 128 
Conditional logistic regression was used to assess the association between signs/symptoms and case 129 
control (RA) status, allowing for the matched design in each of the time periods described above. 130 
Results are presented as unadjusted odds ratios and then adjusted for the rate of consultations (as 131 
defined above) in the period in question. All values are presented as odds ratios (OR) with 95% CI. 132 
 133 
Data management and analyses were conducted in Stata 14.2 [30]. 134 
 135 
Approval for this study was granted by the Independent Scientific Advisory Committee of the CPRD 136 
(reference 13_126). 137 
 138 
RESULTS 139 
Sample 140 
Between 2007 and 2012, 4161 people were identified with a first Read code for RA. Of these, 3577 141 
met the criteria for RA using the algorithm described above [24] and were matched to 14287 142 
controls (Table 1). The mean (standard deviation) age of the both cases and controls was 58.8 (14.5) 143 
  
7 
 
years and 66.8% were female (Table 1). Current and previous smoking were more common in cases 144 
than controls. 145 
 146 
Numbers of consultations 147 
For two years prior to the index date, the overall consultation rate was significantly higher in each 148 
month in cases than in controls (Figure 2) (incidence rate ratio 1.22 (1.21, 1.22)). This increase 149 
became more pronounced in the 6 months before the index date and in the final month before, 150 
cases consulted at 2.68 (95% CI 2.61, 2.76) times the rate of controls (mean: 2.39 consultations per 151 
person).  152 
 153 
Signs and symptoms preceding a diagnosis of RA 154 
Articular symptoms 155 
All articular signs/symptoms were associated with a future diagnosis of RA in all time periods in both 156 
unadjusted and adjusted analyses, with the exception of jaw pain which was not significantly 157 
associated with RA following adjustment for the number of consultations in the 0 to 1-month period 158 
(Table 2). In the 0 to 1-month period, joint symptoms (adjusted OR (95% CI), 14.82 (12.48, 17.60)), 159 
and specifically hand problems (61.07 (31.58, 118.10)), were strongly associated with the 160 
development of RA. Palindromic rheumatism occurred only in cases in the 12 months preceding the 161 
index date. The strength of all associations was lessened by adjustment for the number of 162 
consultations (except for jaw pain in the 0 to 6-month period) and associations were generally 163 
stronger for consultations closer to the index date.  164 
 165 
Non-articular symptoms 166 
In the 0 to 1-month period there were four non-articular signs/symptoms that had large (odds 167 
ratio≥6) unadjusted associations with development of RA (morning stiffness, muscle pain: 13.83 168 
(5.11, 37.42) and carpal tunnel syndrome: 2.96 (1.38, 6.34)). All remained strongly and significantly 169 
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associated after adjustment (Table 3). Morning stiffness was recorded in 14 cases (0.39%), but not in 170 
any controls, hence an estimate of the strength of association could not be made.  Unintentional 171 
weight loss was not significantly associated with RA in the month before the index date, but was in 172 
all other time periods (except adjusted analysis in 12 to 24-month period (Supplementary tables)). In 173 
all time periods, there was a significant unadjusted association between fatigue and development of 174 
RA, but this association was attenuated and not significant after adjustment for number of 175 
consultations. No association was seen with sleep problems or flu-like illness (Table 3). 176 
Psychological problems were significantly associated with a higher odds of RA in all unadjusted 177 
analyses (except 0 to 24 months before the index date, where association was positive, but not 178 
significant), but significantly associated with a decreased odds of RA after adjustment.  179 
 180 
Comparison of consultation 0-12 and 12-24 months before the index date 181 
Comparison of the associations of signs/symptoms during the periods 0 to 12-months and 12 to 24-182 
months before the index date suggested that signs/symptoms grouped together (Supplementary 183 
tables). A similar pattern of association was seen in both time periods for fatigue, altered sensations, 184 
postnatal occurrence of RA, weakness, psychological problems and carpal tunnel syndrome. There 185 
was no unadjusted association between sleep and RA in either time period and only after 186 
adjustment in the 12 to 24-month period for falling. Flu-like symptoms were associated with RA in 187 
the 12 to 24-month period (adjusted analyses only (1.46 (1.04, 2.07)), but not closer to the index 188 
date. All articular signs/symptoms and the remaining non-articular signs/symptoms were more 189 
strongly associated with RA in the 0 to 12-month period than in the 12 to 24-month period. This was 190 
particularly noticeable for hand symptoms (aOR 0 to 12-months: 23.75 (18.49, 30.51); 12 to 24-191 
months: 2.70 (2.05, 3.56)), morning stiffness (0 to 12-months: 9.72 (3.84, 24.60); 12 to 24-months: 192 
0.93 (0.08, 10.64)) and muscle pain (0 to 12-months: 3.15 (2.22, 4.47); 12 to 24-months: 1.22 (0.75, 193 
1.97)). 194 
 195 
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DISCUSSION 196 
The rate of consultations increases rapidly in the period before the index date in those with RA 197 
compared to controls, and key signs and symptoms are recorded at a higher rate before an RA 198 
diagnosis. In the final month before the index date, these include all joint symptoms, but particularly 199 
those involving the hand, and the non-articular symptoms morning stiffness, muscle pain and carpal 200 
tunnel syndrome. In longer periods before the index date, there is also an increase in the recording 201 
of other features such as unintentional weight loss. Other symptoms reported by patients in 202 
previous studies (e.g.  fatigue, cramping, poor sleep) [13-16], showed less clear associations. 203 
 204 
The strengths of our study include the large sample size and use of a validated definition of RA [24]. 205 
Whilst it could be argued that the definition had good specificity at the expense of sensitivity, the 206 
exclusion of controls with any record of inflammatory arthropathy should reassure that there was no 207 
contamination of the control group with potential cases. The data for this study were taken from a 208 
high quality database containing a representative sample of individuals in UK primary care. As such, 209 
the results should be generalizable to other primary care settings. Despite its strengths, this study 210 
also has some weaknesses. First, multiple statistical testing, which could result in false positive 211 
associations. Second, we do not know the thought processes of the GPs who coded the 212 
consultations and how this might have affected our findings. This question cannot be answered in 213 
routinely collected data, but would require in-depth interviews with GPs as to their views and clinical 214 
practice. This in itself may prove difficult, as an individual GP will see a new case of RA only rarely 215 
and may not be able to report what action they would take [20]. 216 
 217 
We adjusted our findings for the total number of consultations (days with ≥1 Read coded 218 
consultation) in order to adjust for ascertainment/surveillance bias, whereby the presence of the 219 
patient in the surgery makes it easier for the GP to identify and code signs/symptoms. This 220 
adjustment for number of consultations attenuated the association of a number of signs/symptoms 221 
  
10 
 
(physical functioning, cramps, weakness and restless legs) with RA. This may suggest that these 222 
signs/symptoms are more common in those with RA, but are only recorded in those who attend 223 
more frequently. A similar process may explain the change in direction of association with 224 
psychological problems when adjusting for number of consultations: people with coded 225 
psychological problems consult more frequently and it may be that controls receive psychological 226 
codes, but RA cases receive codes for physical symptoms because these take priority for the GP.  227 
 Due to small numbers, non-significant associations in the final month before the index date should 228 
be interpreted with caution, as they may well represent a type II statistical error, especially where 229 
the signs/symptom was associated with RA in longer time periods and the absolute estimate of the 230 
size of association is similar across time periods (e.g. unintentional weight loss). However, it could be 231 
that these symptoms are simply more common at an earlier stage in the pre-clinical picture of RA 232 
and become less commonly reported or over-shadowed by other symptoms in the final weeks 233 
before the GP suspects RA.  234 
 235 
Previous literature has described the symptoms patients report before a diagnosis of RA [13-16], and 236 
there is a feeling among rheumatologists that they know what symptoms they expect to see in early 237 
RA. However, to our knowledge this is the first paper to consider whether these signs and symptoms 238 
occur in the primary care record, whether they are more common in those who later received a 239 
diagnosis of RA than in those who do not and how long before RA is suspected by the GP these signs 240 
and symptoms are present.  241 
 242 
Within this study, classical features of RA such as hand pain and stiffness were more frequently 243 
coded within the primary care record, and were seen more frequently up to 2 years before the index 244 
date.  However, musculoskeletal symptoms in regions not traditionally associated with early RA (e.g. 245 
neck and shoulder pain) were also reported more frequently by patients who eventually developed 246 
RA. Joint symptoms, particularly in the hands, and other well-recognised non-articular features 247 
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should raise the index of suspicion of RA in patient presenting in primary care, particularly when 248 
accompanied by a general increase in patient contact with the primary care. However, GPs should 249 
also be aware that these features have low specificity and only a small proportion of patients with 250 
these symptoms will go on to receive a diagnosis of RA. For example, whilst we have confirmed that 251 
people with RA are more likely to have hand symptoms, an RA outcome is seen in only a minority of 252 
patients that have hand symptoms recorded in primary care. Further studies will be needed to 253 
investigate what other symptoms/signs increase the likelihood of an RA diagnosis.  254 
Other early symptoms reported by patients such as falls and sleep problems did not show any 255 
association with RA. This may represent a true lack of association, or it may be that either patients 256 
did not report these symptoms to the GP or that GPs did not code them, especially if they did not fit 257 
with the GP’s concept of what is important. 258 
The association of flu-like symptoms with RA only in the 12 to 24-month period may suggest that 259 
rather than being part of an RA prodrome, flu-like symptoms may be a marker of an insult on the 260 
immune system that reflects the phase of immune tolerance breakage [31]. 261 
 262 
The next steps should be to identify groups of symptoms that constitute a prodrome of RA and at 263 
the same time educate GPs as to the key symptoms that may indicate RA prior to the cardinal 264 
symptoms of morning stiffness and hand symptoms that they already appear to recognise, although 265 
further work is needed to refine the specificity of these common symptoms. 266 
In the future, it may be possible to create automated electronic alerts for the GP within the records 267 
system that highlight the risk for an individual patient when certain codes are entered. This already 268 
happens for example to alert the GP to the possibility of sepsis.  269 
 270 
What our study was not able to do was to identify new signs or symptoms from the record that may 271 
occur at a higher rate in those who go on to receive an RA diagnosis than in those who do not; to do 272 
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so would have required an alternative methodological approach to identify patterns in consultation 273 
that were not defined by code lists (e.g. 32]).  274 
 275 
CONCLUSION 276 
We have provided definitive evidence of the presence of some key features of early RA in the 277 
primary care medical record prior to the GP appearing to recognise the condition. Primary care 278 
professionals should be aware of the range of articular and non-articular features, specifically hand 279 
symptoms, muscle pain, carpal tunnel syndrome and unintentional weight loss, accompanied by an 280 
increased rate of consultation, as potentially forming a prodromal syndrome for RA. Increased 281 
awareness of these symptoms combined with education on the need for early referral could 282 
facilitate earlier treatment of RA, increasing the likelihood of remission and reducing long term joint 283 
damage and comorbidities. 284 
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Figure Legends 406 
Figure 1 Schematic representation of data set 407 
Figure 2 Consultation rates (per person year) in cases and controls prior to index date 408 
